Managed Account Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$7.7M Buy
300,060
+36,723
+14% +$930K 0.01% 1213
2015
Q1
$6.65M Buy
263,337
+21,541
+9% +$525K 0.01% 1288
2014
Q4
$5.75M Buy
241,796
+33,966
+16% +$752K 0.01% 1333
2014
Q3
$4.09M Buy
207,830
+83,975
+68% +$1.73M ﹤0.01% 1475
2014
Q2
$2.96M Buy
123,855
+58,874
+91% +$1.42M ﹤0.01% 1612
2014
Q1
$1.73M Buy
+64,981
New +$1.54M ﹤0.01% 1789

Other funds holding GMED

Managed Account Advisors's GMED Position: Q2 2015 in Review

Managed Account Advisors increased its Globus Medical (GMED) stake by 14% in Q2 2015, buying an estimated $930K and bringing the position to 300,060 shares worth $7.7M. The position accounts for 0.01% of the portfolio, ranked #1213.

Managed Account Advisors first reported a position in GMED in Q1 2014 and has held it in 6 quarters since. 180 funds tracked by Wall St. Rank hold GMED as of Q2 2015.

  • Managed Account Advisors held 300,060 shares of Globus Medical worth $7.7M as of Q2 2015.
  • Managed Account Advisors bought 36,723 Globus Medical shares in Q2 2015, an estimated $930K.
  • Globus Medical made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1213 holding.
  • Managed Account Advisors first reported a position in Globus Medical in Q1 2014 and has held it in 6 quarters since.
  • 180 funds tracked by Wall St. Rank held Globus Medical as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.